The ACR has a wide range of programs to support investigations in rheumatology
Within Our Reach: Collaborating to Find a Cure for RA
Research is critically important to find cures and accelerate patient care for the millions who suffer from arthritis and rheumatic disease. Despite its prevalence in the population and recent treatment advances, rheumatoid arthritis (RA) remains an incurable disease and receives disproportionately less research funding from federal sources than most other autoimmune diseases. This is precisely why the ACR Research and Education Foundation (REF) launched Within Our Reach: Finding a Cure for Rheumatoid Arthritis to directly invest in the types of innovative research not being done elsewhere in the country.
Without You, ACR REF Wouldn’t Be Here
In 1998, the ACR Research and Education Foundation (REF) funded a total of $500,000 in grants. This year, the REF funded more than $4.6 million in grants through its core portfolio, which is an increase of over $4 million in funding capabilities in just 10 years. The REF also achieved the distinction of becoming the second largest funding source—just behind the National Institutes of Health (NIH)—of rheumatology research and training programs in the United States and was recently awarded the prestigious four-star rating from Charity Navigator. These achievements could not have been realized without the generous financial support of REF donors.
Stimulus Package Creates Flurry of Research Funds
Researchers celebrate boon, but wonder what will happen next
Research Across the Spectrum
NIAMS director highlights innovative research initiatives
In America’s Recession, the REF Remains Strong
According to a survey conducted in October 2008 by the Washington Regional Association of Grantmakers, three-quarters of the region’s leading foundations and corporate giving programs suffered a decline in assets because of plummeting returns on investments over 2008. About one-third of the respondents said they reduced grant budgets from 2007 to 2008, and about half of the organizations said they plan to award fewer grants in 2009.
Curing Epidemics at the Strep Lab
A valuable early research education
Enact Change in RA
Future advances could be challenged by structural barriers within the specialty
Bridge Funding Award Keeps Researcher on the Path to Her Passion
On June 25, 2008, the American College of Rheumatology Research and Education Foundation received a letter from Sujata Sarkar, MD, one of the first recipients of the ACR REF/Arthritis Foundation Bridge Funding Award. In that letter Dr. Sarkar wrote, “I am very thankful to you … This award has come to me at a very crucial and vulnerable time in my academic career as a junior researcher.” The crucial and vulnerable time to which Dr. Sarkar refers is the time when she would need to search for alternative funding to pay for her rheumatology research career—or leave academia altogether.
REF and AF Partner to Provide an Additional “Bridge Funding”
Fostering promising investigators is imperative to the future of rheumatology, so when the ACR Research and Education Foundation (REF) board of directors discovered that outstanding applicants were not being funded through the National Institutes of Health (NIH) K-series grant program (the NIH’s career development award program) due to budgetary constraints, the REF quickly called a meeting with the Arthritis Foundation (AF) and the NIH to discuss a solution.